We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

86 hedge funds and large institutions have $121M invested in Adverum Biotechnologies in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more call options, than puts

Call options by funds: $129K | Put options by funds: $52K

8% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 24

0.6% more ownership

Funds ownership: 5.51% → 6.11% (+0.6%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

15% less funds holding

Funds holding: 101 → 86 (-15)

50% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 28

55% less capital invested

Capital invested by funds: $269M → $121M (-$148M)

Holders
86
Holders Change
-15
Holders Change %
-14.85%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
26
Reduced
24
Closed
28
Calls
$129K
Puts
$52K
Net Calls
+$77K
Net Calls Change
-$2.37M

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$24.7M
2
EAM
Eventide Asset Management
Massachusetts
+$4.66M
3
UBS Group
UBS Group
Switzerland
+$3.46M
4
BlackRock
BlackRock
New York
+$3.07M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.84M

Top Sellers

Rank Fund Capital Flow
1
MSU
Mizuho Securities USA
New York
-$60.5M
2
DCM
Driehaus Capital Management
Illinois
-$11.3M
3
CHP
Castle Hook Partners
New York
-$6.55M
4
RSCM
Rock Springs Capital Management
Maryland
-$5.45M
5
Alkeon Capital Management
Alkeon Capital Management
New York
-$4.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$19.7M +$24.7M +607,202 +3,285%
BlackRock
2
BlackRock
New York
$14M +$3.07M +75,373 +20%
Renaissance Technologies
3
Renaissance Technologies
New York
$11.7M +$713K +17,527 +5%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$9.45M – – –
JP Morgan Chase
5
JP Morgan Chase
New York
$9.22M +$648K +15,924 +6%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$5.57M +$515K +12,652 +8%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.19M -$2.44M -59,895 -27%
Citadel Advisors
8
Citadel Advisors
Florida
$4.77M +$2.84M +69,866 +86%
WM
9
WS Management
Florida
$4.05M +$551K +13,540 +12%
EAM
10
Eventide Asset Management
Massachusetts
$3.61M +$4.66M +114,658 New
Primecap Management
11
Primecap Management
California
$3.31M +$882K +21,690 +26%
State Street
12
State Street
Massachusetts
$2.88M -$78.1K -1,919 -2%
UBS Group
13
UBS Group
Switzerland
$2.74M +$3.46M +85,107 +4,294%
B
14
Bpifrance
France
$2.61M +$3.37M +82,826 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$2.2M +$468K +11,517 +20%
Northern Trust
16
Northern Trust
Illinois
$1.9M -$37.7K -928 -2%
Man Group
17
Man Group
United Kingdom
$1.71M -$81.4K -2,000 -4%
SFSIG
18
San Francisco Sentry Investment Group
California
$1.51M – – –
6CM
19
683 Capital Management
New York
$1.14M +$1.36M +33,385 +1,170%
PA
20
Perceptive Advisors
New York
$960K +$1.22M +30,000 New
Two Sigma Investments
21
Two Sigma Investments
New York
$859K +$356K +8,743 +47%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$734K +$78.1K +1,920 +9%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$686K -$7.61K -187 -0.9%
Victory Capital Management
24
Victory Capital Management
Texas
$659K +$255K +6,264 +43%
BCM
25
Bridgeway Capital Management
Texas
$596K – – –
1
2 3 4 5

ADVM Hedge Fund Activity: Q4 2018 in Review

86 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q4 2018, worth a combined $121M — down 55% from $269M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ADVM and 14 opened new positions — a net loss of 14 holders — while 24 trimmed existing stakes and 26 added.

The largest buyer was RTW Investments, adding an estimated $24.7M. The largest seller was Mizuho Securities USA, exiting entirely with an estimated $60.5M sold.

  • 86 institutional investors held Adverum Biotechnologies (ADVM) as of Q4 2018, down from 101 in Q3 2018.
  • Funds reported $121M of Adverum Biotechnologies stock for Q4 2018, down 55% quarter-over-quarter.
  • 14 funds opened new Adverum Biotechnologies positions in Q4 2018 and 28 closed out, a net change of -14 holders.
  • The largest Adverum Biotechnologies buyer in Q4 2018 was RTW Investments, an estimated $24.7M added.
  • The largest Adverum Biotechnologies seller in Q4 2018 was Mizuho Securities USA, an estimated $60.5M sold.

Based on aggregated 13F filings for Q4 2018.